British academic psychiatry at a crossroads: lessons from the past 20years and priorities for the next 20 years

The past twenty years, British academic psychiatry has made significant scientific advances in neurosciences, psychopharmacology, imaging and genetics with patients increasingly being involved as research partners. However, this progress has coincided with marked structural deterioration. Despite a 50% expansion in medical school places and rising mental health needs, full-time academic psychiatrists numbers fell from 330 in 2004 to 206 in 2023. This reduction has constrained research capacity, limited educational opportunities, and exacerbated regional disparities. The current academic landscape is precarious. While research-active services deliver demonstrably better patient outcomes and service outcomes (productivity/efficiency), the research workforce remains small and unevenly distributed. Recent calls to action have emphasised how academic psychiatry must be seen as ‘everyone’s business,’ and highlighted its role in fostering critical thinking, high-quality teaching, and impactful research. In future, sustained investment in workforce development, diversity, and infrastructure is essential. Emerging technologies including digital health, artificial intelligence and precision psychiatry offer transformative possibilities. Regional, networked and virtual academic units can democratise participation and broaden engagement. Academic psychiatry must adopt an entrepreneurial mindset, collaborating with diverse stakeholders, including the private sector. This specialty is indispensable for innovation, clinician development and evidence-based compassionate care for our patients but needs to justify it.